Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevanceMaria Secrier, Rebecca C. Fitzgerald|Nature Genetics|2016Cited by 433
Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancerAnna J. Wiecek, Maria Secrier|Genome biology|2023Cited by 73
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinomaRichard Turkington, Richard D. Kennedy, Andrena McCavigan et al.|Gut|2019Cited by 27
Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancerAnna J. Wiecek, Maria Secrier|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 7
Integrative single-cell and spatial mapping of oxidative stress response uncovers GCLC+ mesenchymal tumor cell state linked with favorable outcomes in triple negative breast cancerNomeda Girnius, Anniina Färkkilä, Tuulia Vallius et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0